tildrakizumab
Drug Details
- Generic Name
- tildrakizumab
- Brand Names
- N/A
- Application Number
- Sponsor
- SAMSUNG BIOLOGICS Co., Ltd.
- NDC Codes
- 1
- Dosage Forms
- LIQUID
- Routes
- N/A
- Active Ingredients
- TILDRAKIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE ILUMYA ® is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMYA is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ( 1 )